---
schema_version: "secwatch.filing_event.v1"
accession: "0001051514-21-000066"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2021-10-04T23:59:59+00:00"
generated_at: "2026-06-28T23:17:32.831693+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# STRATA secures $8M MidCap loan, repays prior debt; names Christopher Lesovitz as new CFO

## Summary
- Entered $8M senior secured term loan with MidCap Financial Trust, drawn Sep 30, 2021; interest at LIBOR (0.50% floor) + 7.50%; matures Sep 1, 2026.
- Repaid $7.275M IDBNY loan and $500K SBA EIDL loan; old debt terminated.
- CFO Matthew Hill resigns effective Oct 15; internal promotion: Christopher Lesovitz named CFO effective Oct 16, 2021.
- Lesovitz receives $250K base salary, up to 50% bonus, $1K/mo car allowance, and options for 250K shares at Oct 18 close.
- MidCap received warrant for 373,626 shares at $1.82, expiring Sep 30, 2031; financial covenant: min trailing rev $24M rising to $30M.

## SEC filing metadata
- accession: 0001051514-21-000066
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2021-10-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000105151421000066/0001051514-21-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000105151421000066/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001051514-21-000066
- JSON: https://secwatch.observer/filing/0001051514-21-000066.json
- Plain text: https://secwatch.observer/filing/0001051514-21-000066.txt

## Key facts
- Executive change
  Christopher Lesovitz was appointed as Chief Financial Officer at STRATA Skin Sciences, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Effective October 16, 2021, the Company appointed Christopher Lesovitz (age 39) as its Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051514/000105151421000066/0001051514-21-000066-index.htm
- Executive change
  Matthew C. Hill resigned as Chief Financial Officer at STRATA Skin Sciences, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On October 4, 2021, Matthew C. Hill, the Company’s Chief Financial Officer, notified the Company of his resignation effective October 15, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051514/000105151421000066/0001051514-21-000066-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.